A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come

by Frederick R. Ueland
Published 2017-03-01

CCNE1 Amplification as a Predictive Biomarker of Chemotherapy Resistance in Epithelial Ovarian Cancer

by Justin W. Gorski, Frederick R. Ueland, Jill M. Kolesar
Published 2020-05-01

Salvaging Detection of Early-Stage Ovarian Malignancies When CA125 Is Not Informative

by Charles J. Dunton, Megan L. Hutchcraft, Rowan G. Bullock, Lesley E. Northrop, Frederick R. Ueland
Published 2021-08-01

Olaparib Combined with an ATR or Chk1 Inhibitor as a Treatment Strategy for Acquired Olaparib-Resistant <i>BRCA1</i> Mutant Ovarian Cells

by Brian T. Burgess, Abigail M. Anderson, J. Robert McCorkle, Jianrong Wu, Frederick R. Ueland, Jill M. Kolesar
Published 2020-02-01

DACH1 mutation frequency in endometrial cancer is associated with high tumor mutation burden.

by McKayla J Riggs, Nan Lin, Chi Wang, Dava W Piecoro, Rachel W Miller, Oliver A Hampton, Mahadev Rao, Frederick R Ueland, Jill M Kolesar
Published 2020-01-01

Lapatinib and poziotinib overcome ABCB1-mediated paclitaxel resistance in ovarian cancer

by J. Robert McCorkle, Justin W. Gorski, Jinpeng Liu, McKayla B. Riggs, Anthony B. McDowell, Nan Lin, Chi Wang, Frederick R. Ueland, Jill M. Kolesar
Published 2021-01-01

Lapatinib and poziotinib overcome ABCB1-mediated paclitaxel resistance in ovarian cancer.

by J Robert McCorkle, Justin W Gorski, Jinpeng Liu, McKayla B Riggs, Anthony B McDowell, Nan Lin, Chi Wang, Frederick R Ueland, Jill M Kolesar
Published 2021-01-01

Utilizing Patient-Derived Epithelial Ovarian Cancer Tumor Organoids to Predict Carboplatin Resistance

by Justin W. Gorski, Zhuwei Zhang, J. Robert McCorkle, Jodi M. DeJohn, Chi Wang, Rachel W. Miller, Holly H. Gallion, Charles S. Dietrich, Frederick R. Ueland, Jill M. Kolesar
Published 2021-08-01

Real-World Evaluation of Universal Germline Screening for Cancer Treatment-Relevant Pharmacogenes

by Megan L. Hutchcraft, Nan Lin, Shulin Zhang, Catherine Sears, Kyle Zacholski, Elizabeth A. Belcher, Eric B. Durbin, John L. Villano, Michael J. Cavnar, Susanne M. Arnold, Frederick R. Ueland, Jill M. Kolesar
Published 2021-09-01

Symptoms Relevant to Surveillance for Ovarian Cancer

by Robert M. Ore, Lauren Baldwin, Dylan Woolum, Erika Elliott, Christiaan Wijers, Chieh-Yu Chen, Rachel W. Miller, Christopher P. DeSimone, Frederick R. Ueland, Richard J. Kryscio, John R. van Nagell, Edward J. Pavlik
Published 2017-03-01

Clinical Factors Associated with Longer Hospital Stay Following Ovarian Cancer Surgery

by Christopher G. Smith, Daniel L. Davenport, Justin Gorski, Anthony McDowell, Brian T. Burgess, Tricia I. Fredericks, Lauren A. Baldwin, Rachel W. Miller, Christopher P. DeSimone, Charles S. Dietrich, Holly H. Gallion, Edward J. Pavlik, John R. van Nagell, Frederick R. Ueland
Published 2019-07-01

Disease-Specific Survival of Type I and Type II Epithelial Ovarian Cancers—Stage Challenges Categorical Assignments of Indolence &amp; Aggressiveness

by Edward J. Pavlik, Christopher Smith, Taylor S. Dennis, Elizabeth Harvey, Bin Huang, Quan Chen, Dava West Piecoro, Brian T. Burgess, Anthony McDowell, Justin Gorski, Lauren A. Baldwin, Rachel W. Miller, Christopher P. DeSimone, Charles Dietrich, Holly H. Gallion, Frederick R. Ueland, John R. van Nagell
Published 2020-01-01